NCT06148597Completed
Effects of M-TAPA Block on Pulmonary Functions
Effects of M-TAPA Block on Postoperative Pulmonary Functions in Laparoscopic Bariatric Surgery: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 22 Apr 2025
Brief summary (registry, in English)
Adequate postoperative analgesia is difficult to achieve in patients undergoing laparoscopic sleeve gastrectomy (LSG). Epidural anesthesia is technically difficult due to subcutaneous fat, which increases the risk of serious complications. Moreover, patients in this condition often have comorbidities that require anticoagulation therapy. Although ultrasound-guided Transversus Abdominis Plane (TAP) block may be useful, it is still controversial. Recently, modified thoracoabdominal nerve block via perichondrial approach (M-TAPA) has been reported as a new and promising technique that provides effective analgesia in the anterior and lateral thoracoabdominal wall. The most common reason for hospitalization after laparoscopic surgery is pain after nausea and vomiting. In addition, superficial and tachypneic breathing resulting from the patient's inability to breathe deeply with pain causes closure of small airways and increase in intrapulmonary shunts, resulting in hypoxia. Postoperative pain management is important not only to prevent pain but also to reduce pulmonary complications that may occur due to changes in lung function and to reduce mortality and morbidity by controlling the stress response. In this study, The investigators investigated the effect of modified thoracoabdominal nerve block via perichondrial approach (M-TAPA) on pulmonary function in patients undergoing laparoscopic bariatric surgery under general anesthesia.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1 (actual)
- First submitted
- 20 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 30 May 2024
- Lead sponsor
- Zonguldak Bulent Ecevit University
- Diseases
- Obesity
- NCT number
- NCT06148597
What you commit to
- Study type: Observational
- Participants enrolled: 1
- From 1 Dec 2023 to the primary completion date, 30 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \<18 years and \>65 years
- ASA ≥ IV
- 50% below the expected value in SFT
- Known diaphragmatic paralysis
- Having had a myocardial infarction within 1 month
- Dementia or confusion
- Lack of cooperation
- Those with respiratory disease
- Congestive heart failure
- Unstable hypertension
- Had thoracoabdominal surgery
Who the study is looking for
- Between 18-65 years old
- ASA I-II-III risk group
- Patients whose approval was obtained through an informed consent form
- Will undergo laparoscopic bariatric surgery
- Patients who will cooperate for the PFT test
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zonguldak Bülent Ecevit University Medicine Faculty Coordinator of this site? Confirm its status | Zonguldak | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.